This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
A report in this issue of The Journal (page 1925) outlines the purpose of a registry sponsored by the Subcommittee on Blood Dyscrasias of the Committee on Research of the Council on Drugs. The Registry on Blood Dyscrasias has been set up for the express purpose of alerting the medical profession to the possible toxic effect on blood and bone marrow of drugs or chemical agents. It is not intended to provide statistical information on the incidence of such conditions but to assist physicians in recognizing such possibilities. There may be doubt in some cases as to whether there is a causal relationship between the condition and the use of the substance. The accumulation of a larger number of cases will make it possible to determine with greater certainty whether a causal relationship exists. The untoward side-effect of many of the newer therapeutic agents may not become apparent until the
NEW REGISTRY ON BLOOD DYSCRASIAS. JAMA. 1959;170(16):1931. doi:10.1001/jama.1959.03010160047015
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: